Related Experiment Video
Updated: Jul 7, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Impact of Balloon-Expandable TAVR Valve Deformation and Calcium Distribution on Outcomes in Bicuspid Aortic Valve
Takashi Nagasaka1, Vivek Patel2, Alon Shechter3
1Cedars-Sinai Medical Center, Smidt Heart Institute, Los Angeles, California, USA; Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Gunma, Japan.
Insights
Transcatheter heart valve deformation after TAVR increases mortality in bicuspid aortic valve patients. Annular and outflow tract calcification also heighten risks for mortality and leaflet thrombosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Limited research exists on transcatheter heart valve (THV) deformation and calcium distribution in bicuspid aortic valve (BAV) patients undergoing transcatheter aortic valve replacement (TAVR).
- Understanding these factors is crucial for improving TAVR outcomes in this specific patient population.
Purpose of the Study:
- To evaluate the impact of THV deformation on clinical outcomes in BAV patients undergoing TAVR.
- To assess the influence of calcium distribution on these outcomes, including mortality and leaflet thrombosis.
Main Methods:
- Analysis of 229 BAV patients who underwent TAVR with balloon-expandable valves and had post-TAVR computed tomography (CT).
- Patients were stratified based on THV underexpansion or eccentricity.
- Calcium distribution was assessed via CT, and associations with 3-year all-cause mortality and 30-day leaflet thrombosis were determined.
Main Results:
- Patients with both THV deformation and eccentricity had higher all-cause mortality and leaflet thrombosis risk.
- Annular and left ventricular outflow tract calcification were independent predictors of mortality and leaflet thrombosis.
- In type 1 BAV patients, calcification at the raphe and opposite leaflet correlated with 3-year all-cause mortality.
Conclusions:
- THV deformation post-TAVR is significantly associated with increased all-cause mortality in BAV patients.
- Annular and left ventricular outflow tract calcification are linked to higher risks of mortality and leaflet thrombosis after TAVR in BAV patients.
Background:
Research on the role of transcatheter heart valve (THV) deformation and calcium distribution in patients with bicuspid aortic valves (BAVs) undergoing transcatheter aortic valve replacement (TAVR) remains limited.
Objectives:
The aim of this study was to evaluate the impact of THV deformation on clinical outcomes in individuals with BAVs undergoing TAVR and the influence of calcium on these outcomes.
Methods:
In total, 229 consecutive patients with BAVs who underwent TAVR with balloon-expandable valves and had computed tomography (CT) performed 30 days post-TAVR were analyzed. Patients were stratified into 3 groups: group 1 (n = 125), with no THV underexpansion or eccentricity; group 2 (n = 69), with underexpansion or eccentricity; and group 3 (n = 35), with both. Calcium distribution was assessed using CT, and its associations with clinical outcomes, including all-cause mortality at 3 years and leaflet thrombosis at 30 days, were determined. A subgroup analysis of patients with type 1 BAVs was conducted.
Results:
Group 3 exhibited higher rates of all-cause mortality than the other groups, along with the highest risk for hypoattenuated leaflet thickening at 30 days. Multivariate analysis identified annular and left ventricular outflow tract calcification as independent predictors of all-cause mortality and hypoattenuated leaflet thickening. In patients with type 1 BAVs, excessive calcification at the raphe and opposite leaflet were associated with all-cause mortality at 3 years.
Conclusions:
THV deformation post-TAVR was significantly linked to all-cause mortality in patients with BAVs. Annular and left ventricular outflow tract calcification correlated with increased risks for all-cause mortality and leaflet thrombosis. (Assessment of Transcatheter and Surgical Aortic Bioprosthetic Valve Thrombosis and Its Treatment With Anticoagulation [RESOLVE]; NCT02318342).
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management

